Update: 16.05.2022
Last week: 18 week 2022 (02.05.2022 - 08.05.2022)
Last full month: Apr 2022
По результатам апреля рынок ЛС ожидаемо откатился назад, компенсируя аномальный март – -27,1% в категории НПВП и -41,2% по категории Милдродата (в упаковках)
В апреле бренды Grindex продолжают удерживать позиции в своих категориях и расти по доле рынка (+0,2 п.п. Капсикам, +0,4 п.п. Милдронат, +0,1 п.п. Сульфаргин)
Теперь коротко по брендам:
МИЛДРОНАТ
+24,0% volume / +65.2% value (YTD)
Милронат продолжает небольшой поступательный рост в деньгах. На фоне рекламной кампании растут продажи новых sku (#20 и #90)
ВИПРОСАЛ
+ 27,6% volume / + 38,3% value (YTD)
Общие результаты YTD на стабильно высоком уровне
КАПСИКАМ
-2.2% volume / -0.8% value (YTD)
Рост доли рынка в апреле (+0,2 п.п.), но ждем большего от ТВ флайта
СУЛЬФАРГИН
+ 5,0% volume / + 11,6% value (YTD)
Отличная динамика продаж на 17 и 18 неделях по обоим sku
АПИЛАК
+ 2,6% volume / + 32,1% value (YTD)
Без значимых изменений в динамике за прошедшие 3 недели
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | |||||||||
| WoW | 2 077 | -3.6% | 56.7% | 3 | 984 001 | -3.5% | 83.0% | 1.8 | -8.7% |
| MoM | 8 817 | -34.6% | 53.5% | -4.3 | 4 250 643 | -36.0% | 81.2% | -3 | -29.4% |
| YTD | 46 010 | 2.6% | 55.0% | -4 | 21 513 648 | 32.1% | 82.3% | 0.9 | 10.0% |
| MAT | 118 778 | -16.6% | 54.2% | -7 | 50 842 476 | 10.7% | 80.7% | -0.7 | -5.8% |
| KAPSIKAM | |||||||||
| WoW | 19 321 | -0.1% | 2.7% | 0.1 | 8 378 215 | -0.2% | 2.9% | 0.2 | -4.4% |
| MoM | 169 728 | -20.9% | 2.7% | 0.2 | 74 220 018 | -20.8% | 2.9% | 0.4 | -27.1% |
| YTD | 399 017 | -2.2% | 2.7% | -0.1 | 169 272 174 | -0.8% | 2.9% | -0.5 | 0.6% |
| MAT | 1 056 171 | -14.2% | 2.6% | -0.2 | 437 543 805 | -8.5% | 2.9% | -0.4 | -7.4% |
| MILDRONATE | |||||||||
| WoW | 80 674 | -10.6% | 21.9% | -0.9 | 54 283 585 | -9.9% | 23.5% | -0.7 | -6.9% |
| MoM | 399 925 | -40.3% | 22.9% | 0.4 | 269 107 725 | -36.4% | 24.2% | 1.1 | -41.2% |
| YTD | 2 082 031 | 24.0% | 16.8% | 1.9 | 1 164 744 998 | 65.2% | 17.9% | 3.9 | 9.8% |
| MAT | 5 199 320 | 15.1% | 17.1% | 2.2 | 2 393 048 134 | 31.7% | 16.3% | 2.6 | 0.4% |
| SULFARGIN | |||||||||
| WoW | 2 989 | 16.6% | 0.9% | 0.1 | 1 564 277 | 17.8% | 1.3% | 0.2 | -1.2% |
| MoM | 11 103 | -27.8% | 0.8% | 0.1 | 5 749 879 | -26.5% | 1.1% | 0.2 | -35.6% |
| YTD | 56 843 | 5.0% | 0.8% | 0.1 | 28 411 279 | 11.6% | 1.1% | 0.1 | -3.5% |
| MAT | 166 844 | -13.8% | 0.9% | -0.1 | 82 716 363 | -2.9% | 1.2% | 0 | -6.9% |
| VIPROSAL | |||||||||
| WoW | 22 159 | -2.8% | 2.9% | 0 | 9 392 729 | -2.5% | 3.1% | 0.1 | -4.4% |
| MoM | 97 455 | -35.9% | 2.9% | -0.4 | 41 743 859 | -36.5% | 3.1% | -0.2 | -27.2% |
| YTD | 511 911 | 27.6% | 3.3% | 0.7 | 211 792 605 | 38.3% | 3.5% | 0.6 | 1.1% |
| MAT | 1 354 192 | 2.6% | 3.2% | 0.3 | 529 924 887 | 9.9% | 3.3% | 0.2 | -7.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 46 010 | 2.6% | 55.0% | -4 | 21 513 648 | 32.1% | 82.3% | 0.9 | 10.0% |
| KAPSIKAM | 399 017 | -2.2% | 2.7% | -0.1 | 169 272 174 | -0.8% | 2.9% | -0.5 | 0.6% |
| MILDRONATE | 2 082 031 | 24.0% | 16.8% | 1.9 | 1 164 744 998 | 65.2% | 17.9% | 3.9 | 9.8% |
| SULFARGIN | 56 843 | 5.0% | 0.8% | 0.1 | 28 411 279 | 11.6% | 1.1% | 0.1 | -3.5% |
| VIPROSAL | 511 911 | 27.6% | 3.3% | 0.7 | 211 792 605 | 38.3% | 3.5% | 0.6 | 1.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 118 778 | -16.6% | 54.2% | -7 | 50 842 476 | 10.7% | 80.7% | -0.7 | -5.8% |
| KAPSIKAM | 1 056 171 | -14.2% | 2.6% | -0.2 | 437 543 805 | -8.5% | 2.9% | -0.4 | -7.4% |
| MILDRONATE | 5 199 320 | 15.1% | 17.1% | 2.2 | 2 393 048 134 | 31.7% | 16.3% | 2.6 | 0.4% |
| SULFARGIN | 166 844 | -13.8% | 0.9% | -0.1 | 82 716 363 | -2.9% | 1.2% | 0 | -6.9% |
| VIPROSAL | 1 354 192 | 2.6% | 3.2% | 0.3 | 529 924 887 | 9.9% | 3.3% | 0.2 | -7.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 2 077 | -3.6% | 56.7% | 3 | 984 001 | -3.5% | 83.0% | 1.8 | -8.7% |
| KAPSIKAM | 19 321 | -0.1% | 2.7% | 0.1 | 8 378 215 | -0.2% | 2.9% | 0.2 | -4.4% |
| MILDRONATE | 80 674 | -10.6% | 21.9% | -0.9 | 54 283 585 | -9.9% | 23.5% | -0.7 | -6.9% |
| SULFARGIN | 2 989 | 16.6% | 0.9% | 0.1 | 1 564 277 | 17.8% | 1.3% | 0.2 | -1.2% |
| VIPROSAL | 22 159 | -2.8% | 2.9% | 0 | 9 392 729 | -2.5% | 3.1% | 0.1 | -4.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 8 817 | -34.6% | 53.5% | -4.3 | 4 250 643 | -36.0% | 81.2% | -3 | -29.4% |
| KAPSIKAM | 169 728 | -20.9% | 2.7% | 0.2 | 74 220 018 | -20.8% | 2.9% | 0.4 | -27.1% |
| MILDRONATE | 399 925 | -40.3% | 22.9% | 0.4 | 269 107 725 | -36.4% | 24.2% | 1.1 | -41.2% |
| SULFARGIN | 11 103 | -27.8% | 0.8% | 0.1 | 5 749 879 | -26.5% | 1.1% | 0.2 | -35.6% |
| VIPROSAL | 97 455 | -35.9% | 2.9% | -0.4 | 41 743 859 | -36.5% | 3.1% | -0.2 | -27.2% |
Abbreviations
WoW - Week Over Week Change = Sales of the last week / Sales of the previous week - 1
MoM - Month Over Month Change = Sales of the last full month / Sales of the previous full month - 1
YTD - Year to Date - a period of time beginning the first day of the current calendar year up to the current date
MAT - Moving Annual Total - a period, being any 12 month period ending on the last week
MS - Market Share
Data Sources:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs